![Published Research](https://mackinstitute.wharton.upenn.edu/wp-content/uploads/2016/06/Published-Research-150x100.png)
Biotech startups increasingly turn to corporate venture capital (VC) arms for funding, rather than to traditional venture capitalists. The innovation implications for these startups remain unexplored. Here, we present evidence that the shift in funding patterns is associated with a greater output of scientific publications as well as patenting.…Read More